AIM/EAH (AIM/EAH)

London Stock Exchange AIM: AIM/EAH · GBX

GBX 94.9

-0.62 (-0.7%)· Recorded snapshot

Market cap	64.3M
Revenue (ttm)	87.5M
Net income (ttm)	2.2M
EPS (ttm)	GBX 0.03
Shares out	67.8M
P/E (trailing)	30.1x
P/E (forward)	25.2x
Volume	16,150
Beta	-0.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.5M
Net income (ttm): 2.2M
EPS (ttm): GBX 0.03
P/E (trailing): 30.1x
P/E (forward): 25.2x
Market cap: 64.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.2

P25 n/aP50 n/aP75 n/a

Trailing P/E30.1

P25 n/aP50 n/aP75 n/a

ROE3.8

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All AIM/EAH indicators

Market & fundamental data

Available fields

257

Groups with data

Currency

GBP

Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Earnings date	2026-11-27
Employees	213
Employees change	-11
Employees growth	-4.91%
Enterprise value	GBX 52.2M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	March
Founded	1972
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	GB0032036807
Last earnings date	2026-07-15
Last refreshed	2026-10-28
Last stock split date	2002-10-18
Last stock split type	Forward
Market cap	GBX 64.3M
Next earnings date	2026-11-27
Price	GBX 94.88
Price currency	GBX
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	aim/EAH
Website	https://ecoanimalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	22.32x
Average P/E ratio (10Y)	48.5x
Average P/E ratio (3Y)	45.9x
Average P/E ratio (5Y)	63.9x
Earnings yield	3.32%
EV/Earnings	24.03x
EV/EBIT	9.15x
EV/EBITDA	6.25x
EV/FCF	7.05x
EV/Sales	0.6x
FCF / EV yield	14.18%
FCF yield	11.53%
Forward P/E	25.22x
Graham number	95.446
Graham upside	-0.06%
Industry forward P/E	16.83x
Industry P/E	20.85x
Lynch fair value	GBX 15.75
Lynch upside	-83.51%
P/(FCF - SBC) ratio	9.07x
P/(OCF - SBC) ratio	8.83x
P/B ratio	0.68x
P/E ratio	30.12x
P/FCF ratio	8.67x
P/OCF ratio	8.45x
P/S ratio	0.74x
Price / tangible book value	1.51x
Price/EBITDA ratio	8.38x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.53%
EBITDA margin	8.82%
Effective tax rate	32.74%
FCF margin	8.53%
Gross margin	48.55%
Operating margin	6.53%
Pretax margin	6.21%
Profit margin	2.5%
Profit per employee	GBX 10,282
Profitable quarters	1
Profitable years	4
Revenue per employee	GBX 410,915
ROA	2.99%
ROA (5Y)	2.28%
ROCE	5.74%
ROE	3.84%
ROE (5Y)	2.26%
ROIC	5.13%
ROIC (5Y)	2.77%
SBC / revenue	0.38%
Tax / revenue	2.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	29.63%
EPS growth (Q)	-24.53%
EPS growth 10Y	-10.51%
EPS growth 3Y	28.92%
EPS growth 5Y	-21.91%
EPS growth years	4
FCF growth	-26.05%
FCF growth (Q)	-11.49%
FCF growth 3Y	-15.44%
FCF growth 5Y	-8.71%
Gross profit growth	18.33%
Gross profit growth (Q)	1.75%
Gross profit growth 3Y	3.46%
Gross profit growth 5Y	-4.23%
Net income growth	29.89%
Net income growth (Q)	-24.53%
Net income growth 3Y	29.52%
Net income growth 5Y	-21.48%
Net income growth years	4
OCF growth	-26.73%
OCF growth (Q)	-12.53%
OCF growth 10Y	11.89%
OCF growth 3Y	-21.63%
OCF growth 5Y	-8.57%
Operating income growth	70.84%
Operating income growth (Q)	-18.28%
Operating income growth 3Y	4.95%
Operating income growth 5Y	-21.72%
Revenue growth	9.96%
Revenue growth (Q)	3.69%
Revenue growth (QoQ)	22.15%
Revenue growth 10Y	6.38%
Revenue growth 3Y	0.86%
Revenue growth 5Y	-3.69%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -192,000
Depreciation and amortization	GBX 2M
EBIT	GBX 5.7M
EBITDA	GBX 7.7M
EPS	GBX 0.03
FCF per share	GBX 0.11
Financing cash flow	GBX -4.2M
Free cash flow	GBX 7.5M
Free cash flow minus SBC	GBX 7.1M
Gross profit	GBX 42.5M
Income taxes	GBX 1.8M
Investing cash flow	GBX -3.7M
Net borrowing	GBX -674,000
Net cash flow	GBX 426,000
Net income	GBX 2.2M
Operating cash flow minus SBC	GBX 7.3M
Operating income	GBX 5.7M
Revenue	GBX 87.5M
Stock-based compensation	GBX 330,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.07
Book value per share	GBX 1.29
Debt / EBITDA	0.59
Debt / equity	0.05
Debt / FCF	0.66
Goodwill	GBX 17.9M
Interest coverage	14.33
Long-term assets	GBX 54.1M
Long-term liabilities	GBX 4.2M
Net cash (debt)	GBX 20.5M
Net cash / market cap	31.68%
Net cash growth	-3.4%
Net debt / EBITDA	-2.66
Net debt / equity	-0.21
Net debt / FCF	-2.75
Piotroski F-Score	7
Property, plant and equipment	GBX 8M
Shareholders' equity	GBX 95.5M
Tangible book value	GBX 42.8M
Tangible book value per share	GBX 0.63
Total assets	GBX 118.6M
Total cash	GBX 25.4M
Total debt	GBX 4.9M
Total liabilities	GBX 23.1M
WACC	4.27%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.73
Current assets	GBX 64.5M
Current liabilities	GBX 18.9M
Current ratio	3.42
Inventory turnover	3.21
Net working capital	GBX 21M
Quick ratio	2.63
Working capital	GBX 45.6M
Working capital turnover	1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.08%
Dividend growth (10Y)	-10.4%
Dividend growth (3Y)	-52.28%
Dividend growth (5Y)	-29.4%
Dividend per share	GBX 0.00
Last dividend	GBX 0.01
Shareholder yield	-0.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-80.83%
10Y return CAGR	-14.62%
10Y total return	-79.42%
150-day SMA	GBX 95.23
15Y price change	-56.58%
15Y return CAGR	-4.38%
15Y total return	-48.92%
1D price change	-0.65%
1M price change	-3.68%
1M total return	-3.68%
1W price change	-0.65%
1W total return	-0.65%
1Y price change	14.31%
1Y return CAGR	14.32%
1Y total return	14.31%
20-day SMA	GBX 95.55
200-day SMA	GBX 97.45
20Y price change	-68.43%
20Y return CAGR	-3.98%
20Y total return	-55.66%
3M price change	-0.65%
3M total return	-0.65%
3Y price change	-12.56%
3Y return CAGR	-4.37%
3Y total return	-12.56%
50-day SMA	GBX 97.25
50-day SMA vs 200-day SMA	50under200
52-week high	GBX 116.90
52-week high date	2026-01-12
52-week low	GBX 80.01
52-week low date	2025-11-05
5Y price change	-64.53%
5Y return CAGR	-18.73%
5Y total return	-64.53%
6M price change	0.93%
6M total return	0.93%
All-time high	GBX 685.00
All-time high date	2017-08-08
All-time low	GBX 33.33
All-time low date	1992-12-24
Average true range (ATR)	GBX 2.64
Average volume	215.9K
Beta (1Y)	0.77
Beta (2Y)	0.58
Beta (5Y)	-0.01
Change from 52-week high	-18.84%
Change from 52-week low	18.58%
Change from all-time high	-86.15%
Change from all-time low	184.65%
Change from open	-0.01%
Day's gap	-0.65%
Dollar volume	GBX 1.5M
High price	GBX 97.00
Low price	GBX 94.00
Monthly RSI	49.9
Open price	GBX 94.88
Position in 52-week range	29.17%
Previous close	GBX 95.50
Price vs 150-day SMA	-0.37%
Price vs 20-day SMA	-0.71%
Price vs 200-day SMA	-2.64%
Price vs 50-day SMA	-2.44%
Relative volume	0.23
RSI	46.28
Sharpe ratio	0.46
Sharpe ratio (3Y)	0.01
Sharpe ratio (5Y)	-0.34
Sortino ratio	0.96
Sortino ratio (3Y)	0.17
Sortino ratio (5Y)	-0.36
Volume	16.2K
Weekly RSI	49.16
YTD price change	-9.21%
YTD total return	-9.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	59.3M
Shares change (QoQ)	5.12%
Shares change (YoY)	0.08%
Shares held by insiders	10.2%
Shares held by institutions	89.38%
Shares outstanding	67.8M

Deeper analysis on AIM/EAH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this AIM/EAH report

Is a complete AIM/EAH research report available?

No complete published report is available for aim/EAH (AIM/EAH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

64.3M

Revenue (ttm)

87.5M

Net income (ttm)

2.2M

EPS (ttm)

GBX 0.03

Shares out

67.8M

P/E (trailing)

30.1x

P/E (forward)

25.2x

Volume

16,150

Beta

-0.01

Metric

Value

Amount currency

GBP

Country

United Kingdom

Country code

Earnings date

2026-11-27

Employees

213

Employees change

-11

Employees growth

-4.91%

Enterprise value

GBX 52.2M

Exchange

London Stock Exchange AIM

Financial currency

GBP

Financial report date

2026-03-31

First seen

2026-05-10

Fiscal year end

March

Founded

1972

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

ISIN number

GB0032036807

Last earnings date

2026-07-15

Last refreshed

2026-10-28

Last stock split date

2002-10-18

Last stock split type

Forward

Market cap

GBX 64.3M

Next earnings date

2026-11-27

Price

GBX 94.88

Price currency

GBX

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

aim/EAH

Website

https://ecoanimalhealth.com

Metric

Value

Adjusted P/E ratio

22.32x

Average P/E ratio (10Y)

48.5x

Average P/E ratio (3Y)

45.9x

Average P/E ratio (5Y)

63.9x

Earnings yield

3.32%

EV/Earnings

24.03x

EV/EBIT

9.15x

EV/EBITDA

6.25x

EV/FCF

7.05x

EV/Sales

0.6x

FCF / EV yield

14.18%

FCF yield

11.53%

Forward P/E

25.22x

Graham number

95.446

Graham upside

-0.06%

Industry forward P/E

16.83x

Industry P/E

20.85x

Lynch fair value

GBX 15.75

Lynch upside

-83.51%

P/(FCF - SBC) ratio

9.07x

P/(OCF - SBC) ratio

8.83x

P/B ratio

0.68x

P/E ratio

30.12x

P/FCF ratio

8.67x

P/OCF ratio

8.45x

P/S ratio

0.74x

Price / tangible book value

1.51x

Price/EBITDA ratio

8.38x

Sector forward P/E

14.52x

Sector P/E

22.58x

Metric

Value

EBIT margin

6.53%

EBITDA margin

8.82%

Effective tax rate

32.74%

FCF margin

8.53%

Gross margin

48.55%

Operating margin

6.53%

Pretax margin

6.21%

Profit margin

2.5%

Profit per employee

GBX 10,282

Profitable quarters

Profitable years

Revenue per employee

GBX 410,915

ROA

2.99%

ROA (5Y)

2.28%

ROCE

5.74%

ROE

3.84%

ROE (5Y)

2.26%

ROIC

5.13%

ROIC (5Y)

2.77%

SBC / revenue

0.38%

Tax / revenue

2.03%

Metric

Value

EPS growth

29.63%

EPS growth (Q)

-24.53%

EPS growth 10Y

-10.51%

EPS growth 3Y

28.92%

EPS growth 5Y

-21.91%

EPS growth years

FCF growth

-26.05%

FCF growth (Q)

-11.49%

FCF growth 3Y

-15.44%

FCF growth 5Y

-8.71%

Gross profit growth

18.33%

Gross profit growth (Q)

1.75%

Gross profit growth 3Y

3.46%

Gross profit growth 5Y

-4.23%

Net income growth

29.89%

Net income growth (Q)

-24.53%

Net income growth 3Y

29.52%

Net income growth 5Y

-21.48%

Net income growth years

OCF growth

-26.73%

OCF growth (Q)

-12.53%

OCF growth 10Y

11.89%

OCF growth 3Y

-21.63%

OCF growth 5Y

-8.57%

Operating income growth

70.84%

Operating income growth (Q)

-18.28%

Operating income growth 3Y

4.95%

Operating income growth 5Y

-21.72%

Revenue growth

9.96%

Revenue growth (Q)

3.69%

Revenue growth (QoQ)

22.15%

Revenue growth 10Y

6.38%

Revenue growth 3Y

0.86%

Revenue growth 5Y

-3.69%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

GBX -192,000

Depreciation and amortization

GBX 2M

EBIT

GBX 5.7M

EBITDA

GBX 7.7M

EPS

GBX 0.03

FCF per share

GBX 0.11

Financing cash flow

GBX -4.2M

Free cash flow

GBX 7.5M

Free cash flow minus SBC

GBX 7.1M

Gross profit

GBX 42.5M

Income taxes

GBX 1.8M

Investing cash flow

GBX -3.7M

Net borrowing

GBX -674,000

Net cash flow

GBX 426,000

Net income

GBX 2.2M

Operating cash flow minus SBC

GBX 7.3M

Operating income

GBX 5.7M

Revenue

GBX 87.5M

Stock-based compensation

GBX 330,000

Metric

Value

Altman Z-Score

3.07

Book value per share

GBX 1.29

Debt / EBITDA

0.59

Debt / equity

0.05

Debt / FCF

0.66

Goodwill

GBX 17.9M

Interest coverage

14.33

Long-term assets

GBX 54.1M

Long-term liabilities

GBX 4.2M

Net cash (debt)

GBX 20.5M

Net cash / market cap

31.68%

Net cash growth

-3.4%

Net debt / EBITDA

-2.66

Net debt / equity

-0.21

Net debt / FCF

-2.75

Piotroski F-Score

Property, plant and equipment

GBX 8M

Shareholders' equity

GBX 95.5M

Tangible book value

GBX 42.8M

Tangible book value per share

GBX 0.63

Total assets

GBX 118.6M

Total cash

GBX 25.4M

Total debt

GBX 4.9M

Total liabilities

GBX 23.1M

WACC

4.27%

Metric

Value

Asset turnover

0.73

Current assets

GBX 64.5M

Current liabilities

GBX 18.9M

Current ratio

3.42

Inventory turnover

3.21

Net working capital

GBX 21M

Quick ratio

2.63

Working capital

GBX 45.6M

Working capital turnover

1.87

Metric

Value

Buyback yield / dilution

-0.08%

Dividend growth (10Y)

-10.4%

Dividend growth (3Y)

-52.28%

Dividend growth (5Y)

-29.4%

Dividend per share

GBX 0.00

Last dividend

GBX 0.01

Shareholder yield

-0.08%

Metric

Value

10Y price change

-80.83%

10Y return CAGR

-14.62%

10Y total return

-79.42%

150-day SMA

GBX 95.23

15Y price change

-56.58%

15Y return CAGR

-4.38%

15Y total return

-48.92%

1D price change

-0.65%

1M price change

-3.68%

1M total return

-3.68%

1W price change

-0.65%

1W total return

-0.65%

1Y price change

14.31%

1Y return CAGR

14.32%

1Y total return

14.31%

20-day SMA

GBX 95.55

200-day SMA

GBX 97.45

20Y price change

-68.43%

20Y return CAGR

-3.98%

20Y total return

-55.66%

3M price change

-0.65%

3M total return

-0.65%

3Y price change

-12.56%

3Y return CAGR

-4.37%

3Y total return

-12.56%

50-day SMA

GBX 97.25

50-day SMA vs 200-day SMA

50under200

52-week high

GBX 116.90

52-week high date

2026-01-12

52-week low

GBX 80.01

52-week low date

2025-11-05

5Y price change

-64.53%

5Y return CAGR

-18.73%

5Y total return

-64.53%

6M price change

0.93%

6M total return

0.93%

All-time high

GBX 685.00

All-time high date

2017-08-08

All-time low

GBX 33.33

All-time low date

1992-12-24

Average true range (ATR)

GBX 2.64

Average volume

215.9K

Beta (1Y)

0.77

Beta (2Y)

0.58

Beta (5Y)

-0.01

Change from 52-week high

-18.84%

Change from 52-week low

18.58%

Change from all-time high

-86.15%

Change from all-time low

184.65%

Change from open

-0.01%

Day's gap

-0.65%

Dollar volume

GBX 1.5M

High price

GBX 97.00

Low price

GBX 94.00

Monthly RSI

49.9

Open price

GBX 94.88

Position in 52-week range

29.17%

Previous close

GBX 95.50

Price vs 150-day SMA

-0.37%

Price vs 20-day SMA

-0.71%

Price vs 200-day SMA

-2.64%

Price vs 50-day SMA

-2.44%

Relative volume

0.23

RSI

46.28

Sharpe ratio

0.46

Sharpe ratio (3Y)

0.01

Sharpe ratio (5Y)

-0.34

Sortino ratio

0.96

Sortino ratio (3Y)

0.17

Sortino ratio (5Y)

-0.36

Volume

16.2K

Weekly RSI

49.16

YTD price change

-9.21%

YTD total return

-9.21%

Metric

Value

Float

59.3M

Shares change (QoQ)

5.12%

Shares change (YoY)

0.08%

Shares held by insiders

10.2%

Shares held by institutions

89.38%

Shares outstanding

67.8M

AIM/EAH (AIM/EAH)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/EAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/EAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/EAH

Frequently asked questions

AIM/EAH (AIM/EAH)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/EAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/EAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/EAH

Frequently asked questions